Researcher

Juan Wang

Second People’s Hospital of Yibin

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 27, 2026 · JOURNAL ARTICLE

Side branch ballooning in provisional stenting of coronary bifurcation lesions: the case for a selective, imaging- and physiology-guided approach

Frontiers in Cardiovascular Medicine

A clinical review synthesizing mechanistic rationale, randomized trial evidence, and imaging data to propose a selective, physiology-guided framework for side branch ballooning in bifurcation PCI—positioned to inform practice rather than report a new trial result.

Expert GuidanceCardiac Imaging and Diagnostics Cerebrovascular and Carotid Artery Diseases Xuewen Hou

Reported

3-year target-vessel failure (SMA…11.7%

3-year target-vessel failure (SMA…20.8%

Pooled odds ratio for major adver…0.48

JUL 27, 2026 · JOURNAL ARTICLE

Bioactive molecule-derived covalent organic frameworks as biocompatible scaffolds for targeted AKR1B10 inhibition in alcoholic liver disease.

Biomaterials

This is a preclinical study combining transcriptomic analysis, virtual screening, and chemical synthesis followed by testing in animal models, raising mechanistic questions about AKR1B10 and COF scaffolds rather than establishing clinical efficacy.

Hypothesis-GeneratingMicrornas Jialu Zhuang Juan Wang

Reported

ALD patient cohort size33

Healthy control cohort size23

Number of inhibitors identified4